Skeletal Muscle and Subcutaneous Fat Quantity as Prognostic Indicators in Cardiac Amyloidosis
Lower SMI was associated with increased mortality risk in patients with CA, particularly ATTR-CA. The relationship between SATI and mortality was more nuanced: in the overall cohort, medium SATI was associated with higher mortality risk, while in patients with ATTR-CA, lower SATI predicted higher mortality risk.
Authors
- Mazen Hanna (ORCID: https://orcid.org/0000-0002-7251-3003)
- W.H. Wilson Tang (ORCID: https://orcid.org/0000-0002-8335-735X)
- Joshua Longinow (ORCID: https://orcid.org/0000-0002-6826-4665)
- Po‐Hao Chen (ORCID: https://orcid.org/0000-0001-7698-5289)
- Saeid Mirzai (ORCID: https://orcid.org/0000-0002-2579-4965)
Institutions
- Cleveland Clinic (US)
Publication Details
- Journal
- European Journal of Heart Failure
- Published
- 2025-02-19
- DOI
- https://doi.org/10.1002/ejhf.3622
- Citations
- 3
- Primary Topic
- Parathyroid Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 4.29
Funders
- Pfizer
- Alnylam Pharmaceuticals
- Cleveland Clinic
- National Institutes of Health
- Musculoskeletal Research Center, Washington University in St. Louis
- National Heart, Lung, and Blood Institute